Summary & Overview
CPT 93457: Coronary and Bypass Graft Angiography with Right Heart Catheterization
CPT code 93457 is a critical billing code in interventional cardiology, representing a comprehensive procedure that includes coronary angiography, bypass graft angiography, and right heart catheterization. This code is widely used in inpatient hospital settings to assess coronary artery disease and evaluate the function of bypass grafts, providing essential diagnostic information for patient management. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage and reimbursement across the healthcare landscape.
This publication offers an in-depth overview of 93457, detailing its clinical context, typical site of service, and its role in cardiovascular diagnostics. Readers will gain insights into payer coverage, relevant benchmarks, and recent policy updates affecting the use of this code. The analysis also highlights associated clinical specialties and related procedural codes, helping stakeholders understand the broader implications for billing and compliance. With its importance in diagnosing and managing complex cardiac conditions, 93457 remains a cornerstone in cardiovascular care and medical billing.
CPT Code Overview
CPT code 93457 is used to report catheter placement in coronary arteries for coronary angiography, including intraprocedural injections for coronary angiography, imaging supervision and interpretation. This code also covers catheter placement in bypass grafts—such as internal mammary, free arterial, or venous grafts—with intraprocedural injections for bypass graft angiography, as well as right heart catheterization.
Service Type: Cardiovascular / Interventional Cardiology
Typical Site of Service: Inpatient Hospital (Place of Service 21)
Clinical & Coding Specifications
Clinical Context
A patient with a history of coronary artery disease and previous coronary artery bypass graft surgery is admitted to the inpatient hospital (Place of Service 21) for evaluation of chest pain and possible graft patency. The interventional cardiologist performs a comprehensive coronary angiography, which includes catheter placement in native coronary arteries and bypass grafts (such as internal mammary, free arterial, or venous grafts). Intraprocedural injections are administered for angiographic imaging of both the native vessels and grafts. Additionally, a right heart catheterization is performed to assess hemodynamics. This workflow is typical for patients with complex cardiac histories requiring detailed assessment of both native and grafted vessels.
Coding Specifications
-
Modifiers:
-
Modifier
26: Used to indicate the professional component of the service, typically when the physician provides only the interpretation and reporting. -
Modifier
TC: Used to indicate the technical component, typically when the facility provides the equipment, supplies, and technical staff. -
Modifier
59: Used to indicate a distinct procedural service, when multiple procedures are performed and need to be reported separately.
-
-
Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207RC0000X | Cardiovascular Disease Physician |
207RI0011X | Interventional Cardiology Physician |
207R00000X | Internal Medicine Physician |
These taxonomies represent providers specializing in cardiovascular disease, interventional cardiology, and internal medicine, all of whom may be involved in performing or interpreting this procedure.
Related Diagnoses
I27.83: Other pulmonary heart diseases, unspecified group 1 supporting code per LCD- This diagnosis code is relevant for patients with pulmonary heart disease, which may necessitate right heart catheterization and coronary angiography to evaluate cardiac function and vascular status. It supports the medical necessity for the procedure described by
93457.
- This diagnosis code is relevant for patients with pulmonary heart disease, which may necessitate right heart catheterization and coronary angiography to evaluate cardiac function and vascular status. It supports the medical necessity for the procedure described by
Related CPT Codes
-
93451: Right heart catheterization- Used to assess hemodynamics in the right side of the heart. This is included in the primary procedure described by
93457.
- Used to assess hemodynamics in the right side of the heart. This is included in the primary procedure described by
-
93503: Insertion and placement of flow directed catheter- Used for placement of a flow-directed catheter, such as a Swan-Ganz, which may be performed in conjunction with right heart catheterization.
-
93505: Endomyocardial biopsy- May be performed during cardiac catheterization to obtain myocardial tissue samples, often in transplant patients or those with suspected myocarditis.
-
93566: Injection procedure during cardiac catheterization; for selective coronary angiography- Used for selective injection during cardiac catheterization, often performed alongside angiography procedures.
These codes are related to 93457 as they represent procedures commonly performed during comprehensive cardiac catheterization. Some may be used together in complex cases, while others are alternatives or adjuncts depending on clinical need.
National Reimbursement Benchmarks
National mean rates for CPT code 93457 show a significant gap between Medicare and commercial payers. Medicare's mean rate is $825.52, while the BUCA (average commercial) mean rate stands at $1,200.26, reflecting a difference of $374.74 per case.
Rate dispersion varies notably across payers. Aetna has the tightest range, with a difference of $251.71 between its 75th and 25th percentiles. In contrast, Cigna and UnitedHealth Group exhibit the widest spreads, with Cigna's range at $690.79 and UnitedHealth Group's at $701.75. This indicates greater variability in commercial reimbursement compared to Medicare, whose range is $800.00.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.